6-Thioguanine-related hepatotoxicity in patients with inflammatory bowel disease: dose or level dependent?
Luc J J
LJ
Derijks
Lennard P L
LP
Gilissen
Nanne K H
NK
de Boer
Chris J J
CJ
Mulder
D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008099:Liver / Q000473:pathology; D008107:Liver Diseases / Q000175:diagnosis; D015122:Mercaptopurine / Q000627:therapeutic use; D013866:Thioguanine / Q000009:adverse effects* / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D015122:Mercaptopurine; D013866:Thioguanine; D001379:Azathioprine